Practical strategies and tactics for pharma and biopharma companies will be discussed with industry experts on development, manufacturing to commercialisation
Biosimilars Summit India 2018, slated to be held from from May 10-11, 2018 in Mumbai, is a global platform that lays out the roadmap – moving beyond theory to discuss the practical strategies and tactics, for pharma, biopharma companies to succeed in the global biosimilar market. Discussions will be held with industry experts on development, manufacturing to commercialisation – the current landscape, legal, regulatory, funding, challenges, market access strategy, business models and how to get to market.
Topics which will be discussed during the event are:
- Current global biosimilar landscape and policy updates
- Opportunities – Business & Investment models
- Bioanalytics and interchangability
- Legal considerations and market access and commercialisation
- Case Studies – from development to market
- Biosimilar product portfolios and business strategies
- Clinical Studies – Pharmacovigilance challenges
- Biosimilar manufacturing and latest technologies
Who should attend?
Chief Executives, Directors Vice Presidents, Department Head, Leaders and Managers specialising in:
- Biopharma/ Biotherapeutics
- Legal Affairs, Intellectual Property
- Health Economics, Pricing and Reimbursement
- Research and Development, Formulation
- Process Control and Analytical Technologies, Analytical Characterisation
- Pharmacovigilance, Drug Safety & Risk Management
- Regulatory Compliance, Quality Affairs/ Quality Control
- Business Operations, Scientific Affairs, Commercial Affairs
- Portfolio Management, R&D, Business Development
Contact Details:
Rahul Sharma
BD Manager
Mob: +91 989 272 9885
E-mail: [email protected]
- Advertisement -
Comments are closed.